The goal of this proposal is to utilize homologous recombination strategies to generate defined interstitial and terminal deletions of individual human chromosomes. A nested series of interstitial and terminal deletions would aid in generating deletions in the human X-chromosome and using them to map several markers on this chromosome. Interstitial deletions will be generated first in YACs containing human DNA. A recombination vector containing a fragment of human clotting factor IX (F9) at one end and a human repetitive element (LINE 1) at the other with selectable markers in between (HIS3 for yeast and neo for mammalian cells) will be introduced into yeast containing a 650 kb YAC which has the complete F9 gene. Homologous recombination (HR) between the vector and its target sequences in the YAC would result in deletions extending from the F9 to each of several L1 sequences located on the chromosome. Similar experiments will be conducted in rodent-human somatic cell hybrids containing an intact human X-chromosome or part of it translocated onto the tip of a rodent chromosome. HR events will be isolated by selection for G418-resistant colonies followed by screening by the polymerase chain reaction (PCR). Terminal deletions in the human X-chromosome will be generated by targeting the L1 repeat elements with a vector containing a dominant selectable marker and human telomeric sequences. Homologous recombination of the introduced DNA with each of its homologous sequences on the X-chromosome will yield a nested series of terminal deletions. The deletions that are generated will be characterized at the molecular as well as cytological level. An ordered set of deletions of increasing size will be used to map markers on the X-chromosome. The map that is generated will be compared to existing maps. If successful, this strategy could be employed to generate similar deletions in any human chromosome.

Agency
National Institute of Health (NIH)
Institute
National Human Genome Research Institute (NHGRI)
Type
Research Project (R01)
Project #
5R01HG000380-03
Application #
2208798
Study Section
Genome Study Section (GNM)
Project Start
1991-04-01
Project End
1995-03-31
Budget Start
1993-04-01
Budget End
1995-03-31
Support Year
3
Fiscal Year
1993
Total Cost
Indirect Cost
Name
Albert Einstein College of Medicine
Department
Genetics
Type
Schools of Medicine
DUNS #
009095365
City
Bronx
State
NY
Country
United States
Zip Code
10461
Merscher, S; Marondel, I; Pedeutour, F et al. (1997) Identification of new translocation breakpoints at 12q13 in lipomas. Genomics 46:70-7
Yang, K; Edelmann, W; Fan, K et al. (1997) A mouse model of human familial adenomatous polyposis. J Exp Zool 277:245-54
Edelmann, W; Zervas, M; Costello, P et al. (1996) Neuronal abnormalities in microtubule-associated protein 1B mutant mice. Proc Natl Acad Sci U S A 93:1270-5
Marondel, I; Renault, B; Lieman, J et al. (1996) Physical mapping of the human neurotensin gene (NTS) between markers D12S1444 and D12S81 on chromosome 12q21. Genomics 38:243-5
Renault, B; Lieman, J; Ward, D et al. (1995) Localization of the human achaete-scute homolog gene (ASCL1) distal to phenylalanine hydroxylase (PAH) and proximal to tumor rejection antigen (TRA1) on chromosome 12q22-q23. Genomics 30:81-3
Fejzo, M S; Yoon, S J; Montgomery, K T et al. (1995) Identification of a YAC spanning the translocation breakpoints in uterine leiomyomata, pulmonary chondroid hamartoma, and lipoma: physical mapping of the 12q14-q15 breakpoint region in uterine leiomyomata. Genomics 26:265-71
Umanoff, H; Edelmann, W; Pellicer, A et al. (1995) The murine N-ras gene is not essential for growth and development. Proc Natl Acad Sci U S A 92:1709-13
Davies, R L; Yoon, S J; Weissenbach, J et al. (1995) Physical mapping of the human ELA1 gene between D12S361 and D12S347 on chromosome 12q13. Genomics 29:766-8
Pedeutour, F; Merscher, S; Durieux, E et al. (1994) Mapping of the 12q12-q22 region with respect to tumor translocation breakpoints. Genomics 22:512-8
Fodde, R; Edelmann, W; Yang, K et al. (1994) A targeted chain-termination mutation in the mouse Apc gene results in multiple intestinal tumors. Proc Natl Acad Sci U S A 91:8969-73

Showing the most recent 10 out of 13 publications